PATENT CLAIM ANALYSIS

Application Number: 15973569
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "210200"]

Abstract:
Series of 2-phenyl-4-methylthiazole analogues are disclosed as potential therapeutic agents for the treatment of bacterial infections, especially methicillin-resistant  Straphylococcus aureus  (MRSA) related infections. A method for the treatment of MRSA-related infections is also claimed.

Claim (Index 3):
The compound of  claim 1 , wherein R 1  is amino or an alkylamino.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 93.0
- Lexical Diversity: 1.25806
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15144311', '14111157', '14110391', '13388712', '14119673']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8158153254645295
- 35 USC 102 Novelty (BERT): 0.549961858638952
- Combined Prediction Score: 0.7892299787819718
- Mean Citation Score: 379.947854
- Max Citation Score: 431.57492
- Similarity Product: 287.5629217858982

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test